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           For more than 30 years transthoracic external cardioversion has been an established 
method for the restoration of sinus rhythm in patients with persistent atrial fibrillation. It was 
first described by Lown in 19631. Though the success rate for external cardioversion ranges from 
60-90 %2-4, there is reduced efficacy in those patients with a high body-mass index and an 
increased transthoracic diameter 5.                                                         . 
           The method of internal cardioversion for restoration of sinus rhythm using transvenous 
electrodes has been reported in several animal6,7 and human studies8-15. Cooper et al6 tested 
multiple electrode configurations in a sheep model of atrial fibrillation. They demonstrated that 
the optimal single current pathway for internal atrial defibrillation employed two electrodes that 
surrounded both atria (e.g., right atrial appendage and distal coronary sinus). Similar results have 
been reported in several human studies12-14. Internal cardioversion has been shown to be 
superior to conventional external cardioversion in terms of primary success rate, energy 
requirements and the need for sedation; this superiority holds especially true for patients with a 
high   body   mass   index   of   >   25   kg/m2   and   increased   transthoracic   diameter
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           The initial human data has been collected using two separate catheter for internal 
cardioversion. Though this approach demonstrated some advantages, there are also clear 
disadvantages, such as lack of ventricular backup stimulation in cases of post shock bradycardia, 
prolonged fluoroscopy time and the need for venous access via primarily the lower limb. These 
disadvantages   increase   the   risk   of   bleeding   complications,   especially   in   patients   with 
anticoagulation.  
           Recently published data have demonstrated the benefit of a single lead catheter with two 
shock arrays on a balloon guided pulmonary artery catheter, when compared to the previous two 
catheter technique12. Optional ventricular backup pacing, preferable venous access via the upper 
limb, reduced procedural and fluoroscopy time are the major advantages. This new balloon-
tipped cardioversion catheter (fig 1 and 2) resembles a regular Swan-Ganz catheter. A guide-
wire introduced via a central lumen allows facilitated searing and positioning of this device. The 
central   lumen   also   provides   means   to   draw   blood   samples,   infuse   drugs   or   perform 
haemodynamic measurements (pulmonary artery and wedge pressure). The proximal and distal 
high-energy electrode arrays for internal defibrillation consist of six 0.5 cm long platinum rings 
with a total surface area of 2.4 cm2 for each array. The middle ring of the proximal array is 
connected individually for atrial sensing and pacing, while the others are connected in parallel 
(atrial array). One pole located in the right ventricular outflow tract - between both arrays - 
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serves for ventricular pacing and sensing. The six distal pulmonary rings are connected in 
parallel for internal cadioversion shock delivery.
 
Figure 1: Single lead ballon guided cardioversion catheter introduced via the 
right cubital vein. The proximal shock array contacts the basal right atrial 
wall and the distal shock array is positioned in the left pulmonary artery 
 
Figure 2: Same patient as in figure 1. The distal shock array is in the right 
pulmonary artery in a position similar to a regular Swan Ganz catheter for 
haemodynamic monitoring.
        For cardioversion with this new device an electrode configuration in the right atrium and 
left pulmonary artery is suggested. A randomized trial could demonstrate that this configuration 
provides a homogeneous electrical field for effective cardioversion, and slightly higher energy 
requirements compared to a lead position in the right atrium and distal coronary sinus12, as 
described earlier. However the use of single lead catheters with a shock array position proximal 
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in the right atrium and distal in the left pulmonary artery has contributed to facilitate the 
procedure of internal cardioversion of atrial fibrillation considerably.                                
      Ventricular backup pacing is an important safety tool, not only for a subgroup of patients 
with post shock bradycardia, but also for bradycardia after the administration of antiarrhythmic 
drugs or beta-blockers. The possibility of post shock atrial pacing also offers new therapeutic 
options in preventing the early recurrence of atrial fibrillation. Immediately after cardioversion 
60% of all patients develop premature atrial contractions16. Recently published data suggest that 
short   coupling   intervals   of   the   premature   atrial   beat   predict   an   early   relapse   of   atrial 
fibrillation16. Heterogeneity of refractoriness and conduction give way for a premature stimulus 
to  reinduce   atrial   fibrillation.   Immediately   after   cardioversion,   electrical   remodeling   has 
shortened the refractory period of the atria, thereby facilitating relapse16,17. Atrial overdrive 
stimulation after successful internal cardioversion for the prevention of atrial premature beats 
promotes the homogeneity of the atrial wavefront. Atrial stimulation at higher rates therefore can 
prevent early recurrence of atrial fibrillation, thereby contributing to the clinical efficacy of 
internal cardioversion18.                                                                                                          
       For internal cardioversion of atrial fibrillation an electrode position with the distal tip in the 
left pulmonary artery is currently used preferably (fig 1). Due to the manufactured curvature of 
the Swan-Ganz type catheter, this catheter has the tendency to favor the right pulmonary artery 
when advanced normally. Therefore the use of a lead configuration in the right atrium and right 
pulmonary artery would facilitate the procedure of internal cardioversion (fig 2). A recently 
finished study at the Rechts der Isar Medical Center in Munich revealed that the efficacy of 
internal cardioversion of atrial fibrillation with the distal shock array in the right pulmonary 
artery is 88 %. This success rate is somewhat lower than for a positioning in the left pulmonary 
artery. The reason for this difference might only be anticipated. The creation of a homogenous 
electrical field with sufficient strength is mandatory for conversion of ventricular fibrillation13. 
The same may hold true for AF. With respect to homogeneity of field strength, one would 
assume that direct application of the energy to the two areas within or surrounding the heart 
should result in increased myocardial field strength and decreased energy loss. While an 
electrode position in the right atrium and left pulmonary artery creates an electric field vector 
encompassing large areas of both atria, an electrode position right atrium and right pulmonary 
artery does not include parts of the left lateral atrium. This exclusion results in a loss of 
homogeneity of the electric field strength and therefore mandates slightly higher cardioversion 
energies. Nevertheless, the success rates for internal cardioversion with the distal tip in the right 
pulmonary artery is comparable to the efficacy of external cardioversion. This lead position 
furthermore facilitates the internal cardioversion procedure, because the positioning of the single 
lead balloon tipped cardioversion catheter in the right pulmonary artery is comparable to the 
positioning of a regular Swan-Ganz catheter.                                                                          
      Though the design of the cardioversion catheter is similar to a regular Swan-Ganz balloon 
catheter, the cardioversion catheter offers the additional facilities of cardioversion, cardiac pacing 
and, in the newest generation of these electrode systems even haemodynamic measurements by 
means of thermodilution. These qualities render the cardioversion catheter suited for application 
in the electrophysiological laboratory as well as in emergency and intensive care settings. More 
than 30 % of patients undergoing cardiovascular surgery develop persistent atrial fibrillation20. In 
these settings, the new device combines not only routine haemodynamic monitoring, identical to 
a regular Swan-Ganz catheter, but also offers means for effectively cardioverting atrial fibrillation 
without the assistance of an anesthesiologist, a widespread prerequisite for external cardioversion 
procedures in outpatient departments. The balloon guided single lead cardioversion catheter 
offers a valid alternative to external cardioversion, and can be operated by non-cardiologist as 
well. Currently ongoing studies assess the value of the combined Swan-Ganz thermodilution and 
cardioversion-catheter in the postoperative ICU-setting.                                                           
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